245 related articles for article (PubMed ID: 19616698)
1. Intestinal or gastric? The unsolved dilemma of Barrett's metaplasia.
Rugge M; Fassan M; Battaglia G; Parente P; Zaninotto G; Ancona E
Hum Pathol; 2009 Aug; 40(8):1206-7; author reply 1207-8. PubMed ID: 19616698
[No Abstract] [Full Text] [Related]
2. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett's esophagus and adenocarcinoma of the gastrica cardia.
Conio M; Cameron AJ
Gastrointest Endosc; 2001 Dec; 54(6):799-801. PubMed ID: 11762326
[No Abstract] [Full Text] [Related]
3. Letter to the editor regarding "Definition of Barrett's esophagus: time for a rethink-is intestinal metaplasia dead?".
DeMeester SR
Am J Gastroenterol; 2010 May; 105(5):1201-2; author reply 1202-3. PubMed ID: 20445513
[No Abstract] [Full Text] [Related]
4. Where are you and how do we find you? The dilemma of identifying Barrett's epithelium before adenocarcinoma of the esophagus.
Wong RK; Altekruse SF
Am J Gastroenterol; 2009 Jun; 104(6):1363-5. PubMed ID: 19436281
[TBL] [Abstract][Full Text] [Related]
5. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies.
Harrison R; Perry I; Haddadin W; McDonald S; Bryan R; Abrams K; Sampliner R; Talley NJ; Moayyedi P; Jankowski JA
Am J Gastroenterol; 2007 Jun; 102(6):1154-61. PubMed ID: 17433019
[TBL] [Abstract][Full Text] [Related]
6. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
Asthana N; Mandich D; Ligato S
Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240
[TBL] [Abstract][Full Text] [Related]
7. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
8. Immunopathological patterns of the stomach in adenocarcinoma of the esophagus, cardia, and gastric antrum: gastric profiles in Siewert type I and II tumors.
Mattioli S; Ruffato A; Di Simone MP; Corti B; D'Errico A; Lugaresi ML; Mattioli B; D'Ovidio F
Ann Thorac Surg; 2007 May; 83(5):1814-9. PubMed ID: 17462405
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of the nuclear receptors farnesoid X receptor (FXR) and pregnane X receptor (PXR) for grading dysplasia in patients with Barrett's oesophagus.
van de Winkel A; van Zoest KP; van Dekken H; Moons LM; Kuipers EJ; van der Laan LJ
Histopathology; 2011 Jan; 58(2):246-53. PubMed ID: 21323950
[TBL] [Abstract][Full Text] [Related]
10. Is there an advantage to be gained from adding digital image cytometry of brush cytology to a standard biopsy protocol in patients with Barrett's esophagus?
Borovicka J; Schönegg R; Hell M; Kradolfer D; Bauerfeind P; Dorta G; Netzer P; Binek J; Meyenberger C; Fischer JE; Spieler P
Endoscopy; 2009 May; 41(5):409-14. PubMed ID: 19418394
[TBL] [Abstract][Full Text] [Related]
11. Progression of Barrett's esophagus to adenocarcinoma despite antireflux surgery.
von Conrady D; Smith MJ; Khan MF; Tan S; Mortimer G; McAnena OJ
Endoscopy; 2008 Sep; 40 Suppl 2():E68-9. PubMed ID: 18633915
[No Abstract] [Full Text] [Related]
12. Histology of metaplasia and dysplasia in Barrett's esophagus.
Yerian L
Surg Oncol Clin N Am; 2009 Jul; 18(3):411-22. PubMed ID: 19500733
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
14. Barrett's: do we still need goblet cells for diagnosis?
Lenglinger J; Riegler M
Am J Gastroenterol; 2009 Sep; 104(9):2355-6; author reply 2356-7. PubMed ID: 19727095
[No Abstract] [Full Text] [Related]
15. Low-grade dysplasia in Barrett's esophagus - an innocent bystander? Pro.
Wani S; Choi W; Sharma P
Endoscopy; 2007 Jul; 39(7):643-6. PubMed ID: 17611920
[No Abstract] [Full Text] [Related]
16. Targeting surveillance in Barrett's esophagus.
Hillman L
J Gastroenterol Hepatol; 2008 Sep; 23(9):1311-2. PubMed ID: 18853989
[No Abstract] [Full Text] [Related]
17. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
18. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
19. The use of dynamic positron emission tomography imaging for evaluating the carcinogenic progression of intestinal metaplasia to esophageal adenocarcinoma.
Li Y; Woodall C; Wo JM; Zheng H; Ng CK; Ray MB; Martin RC
Cancer Invest; 2008; 26(3):278-85. PubMed ID: 18317969
[TBL] [Abstract][Full Text] [Related]
20. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
